Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the use in this Registration Statement on Form 10-K of our report dated March 20, 2025, relating to the financial statements of Titan Pharmaceuticals, Inc. We also consent to the reference to us under the heading “Experts” in such Registration Statement.